Court won’t seal False Claims suit against RehabCare, despite whistleblower’s fear of retaliation
By
Dec 07, 2016
A whistleblower’s fear of retaliation isn’t sufficient to justify sealing her False Claims Act lawsuit filed against RehabCare Group Inc., a judge ruled on Friday.
Kindred quits: dumping SNFs
By
James M. Berklan
Dec 06, 2016
Kindred Healthcare Inc., which operated more than 200 nursing homes less than a decade ago, is pulling the plug on its skilled nursing facilities.
McKnight’s earns APEX honors
By
Marty Stempniak
Aug 09, 2018
McKnight’s Long-Term Care News has once again earned national honors in the 30th annual APEX Awards for Publication Excellence competition.
Huntington appoints Langenderfer
Sep 01, 2015
John Langenderfer was named Huntington’s director of healthcare sales and origination.
Treatment Update
Jul 01, 2013
Covalon Technologies announced ColActivePlus and ColActive Plus Ag have been assigned Healthcare Common Procedure Coding System codes for Medicare billing. Professionals who use HCPCS codes for DME billing...
Gender-bending thief targets Atlanta assisted living facilities
Dec 22, 2011
It’s unclear from the surveillance video if the thief, donned in nursing scrubs, an identification badge and what appears to be a large black curly wig, is a man or a woman. But one thing is certain:...
Major investor leaves HCR ManorCare: Report
By
Elizabeth Newman
Jun 13, 2017
Private equity and investment firm Carlyle Group is letting go of HCR ManorCare, one of the nation’s largest nursing home chains, according to the New York Post.
Macmillan joins Archway Health
Sep 13, 2017
Keely Macmillan has become the general manager of Archway Health’s BPCI, moving into a new position for the company.
Tutera hires Young as director of HR
Jun 15, 2015
Leslie Young has been hired as director of human resources operations at Tutera Senior Living & Healthcare.
FDA panel approves first biosimilar drug
Mar 10, 2015
The Food and Drug Administration approved its first biosimilar product last week, opening the door for more costly drug alternatives.